Finding the right tests…
Emergency services available 24 x 7
Finding the right tests…
Molecular
Human metapneumovirus, or HMPV, is a respiratory virus first identified in 2001 that belongs to the same viral family as RSV. It spreads through coughing, sneezing, close contact, and touching a contaminated surface before touching your face. Most people are first exposed to it in early childhood and can be reinfected throughout life, usually with a cough, fever, and blocked nose that clears on its own. Cases tend to rise in the colder months. Testing is done with a nasal or throat swab and looks for the virus's genetic material directly, which is why doctors usually reserve it for people with severe symptoms, young children, older adults, or anyone with a weakened immune system, rather than every mild cold.
This test detects HMPV genetic material in a swab from your nose or throat using a molecular method, sometimes alongside an antigen test. A positive result confirms HMPV as the cause of your current respiratory illness, which helps your doctor decide on isolation and rule out infections that need antibiotics. A negative result usually means HMPV isn't behind your symptoms, though the virus can still be missed if the swab is taken very early or very late in the illness. There's no antiviral medicine or vaccine for HMPV, so treatment stays supportive either way.
Human metapneumovirus was first identified in 2001, though evidence suggests it had circulated in people for decades before that. It belongs to the same family as respiratory syncytial virus (RSV) and causes a similar range of illness, from a mild cold to bronchitis or pneumonia in more serious cases.
Most people are exposed to HMPV in early childhood, and reinfection is common throughout life since immunity from a past infection doesn't fully protect you the next time. Because a routine cold caused by HMPV usually needs nothing beyond rest and fluids, testing is generally reserved for people more likely to get seriously ill: infants, older adults, and people with weakened immune systems, or when a doctor needs to tell HMPV apart from flu, COVID-19, or a bacterial infection that needs antibiotics.
A nasal or throat swab goes to the lab, where a molecular test looks for the virus's genetic material directly. This nucleic acid amplification approach is the preferred method because it's more sensitive than testing for viral proteins through an antigen test.
There's no specific antiviral drug or vaccine for HMPV, so a positive result doesn't change treatment much beyond supportive care. What it does change is unnecessary antibiotic use, and it helps guide isolation decisions, especially in a hospital setting or around someone vulnerable.
It's a respiratory virus first identified in 2001 that belongs to the same family as RSV. It causes a range of illness from a mild cold to bronchitis or pneumonia, and most people are exposed to it in early childhood.
HMPV and RSV are related viruses that cause similar symptoms and circulate in similar seasons, which is why they're sometimes tested for on the same swab panel. Telling them apart matters mainly for guiding isolation and outbreak tracking, since treatment for both is largely supportive either way.
It spreads through coughing and sneezing, close contact with an infected person, and touching a surface the virus is on before touching your face. Good hand hygiene and staying home while symptomatic are the main ways to limit spread.
This page is general information about the test, not medical advice. Your own report's reference ranges apply — please discuss your results with your doctor.
No. There's currently no specific antiviral medicine or vaccine for HMPV, so care focuses on rest, fluids, and managing symptoms. Most people recover on their own within a week or two.
Testing is usually reserved for people more likely to get seriously ill, such as young children, older adults, or anyone with a weakened immune system, or when a doctor needs to rule out flu, COVID-19, or a bacterial infection. A routine cold with mild symptoms doesn't usually change management enough to need it.
Adults can get HMPV, and reinfection throughout life is common since immunity from a past infection doesn't fully protect you the next time. Illness in healthy adults is usually milder than in young children or older adults.
Molecular testing, which looks for the virus's genetic material directly, is the preferred and more sensitive method compared with antigen testing. As with any respiratory swab, results can be affected by how and when the sample was collected relative to your symptoms.